Cargando…

Cytotoxic activity in cutaneous leishmaniasis

Cutaneous leishmaniasis (CL) is a chronic disease caused by species of the protozoan Leishmania and characterised by the presence of ulcerated skin lesions. Both parasite and host factors affect the clinical presentation of the disease. The development of skin ulcers in CL is associated with an infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos, Taís M, Costa, Rúbia, Passos, Sara, Carvalho, Lucas P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661895/
https://www.ncbi.nlm.nih.gov/pubmed/29091132
http://dx.doi.org/10.1590/0074-02760170109
_version_ 1783274559038816256
author Campos, Taís M
Costa, Rúbia
Passos, Sara
Carvalho, Lucas P
author_facet Campos, Taís M
Costa, Rúbia
Passos, Sara
Carvalho, Lucas P
author_sort Campos, Taís M
collection PubMed
description Cutaneous leishmaniasis (CL) is a chronic disease caused by species of the protozoan Leishmania and characterised by the presence of ulcerated skin lesions. Both parasite and host factors affect the clinical presentation of the disease. The development of skin ulcers in CL is associated with an inflammatory response mediated by cells that control parasite growth but also contribute to pathogenesis. CD8+ T cells contribute to deleterious inflammatory responses in patients with CL through cytotoxic mechanisms. In addition, natural killer cells also limit Leishmania infections by production of interferon-γ and cytotoxicity. In this review, we focus on studies of cytotoxicity in CL and its contribution to the pathogenesis of this disease.
format Online
Article
Text
id pubmed-5661895
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Instituto Oswaldo Cruz, Ministério da Saúde
record_format MEDLINE/PubMed
spelling pubmed-56618952017-11-04 Cytotoxic activity in cutaneous leishmaniasis Campos, Taís M Costa, Rúbia Passos, Sara Carvalho, Lucas P Mem Inst Oswaldo Cruz Review Cutaneous leishmaniasis (CL) is a chronic disease caused by species of the protozoan Leishmania and characterised by the presence of ulcerated skin lesions. Both parasite and host factors affect the clinical presentation of the disease. The development of skin ulcers in CL is associated with an inflammatory response mediated by cells that control parasite growth but also contribute to pathogenesis. CD8+ T cells contribute to deleterious inflammatory responses in patients with CL through cytotoxic mechanisms. In addition, natural killer cells also limit Leishmania infections by production of interferon-γ and cytotoxicity. In this review, we focus on studies of cytotoxicity in CL and its contribution to the pathogenesis of this disease. Instituto Oswaldo Cruz, Ministério da Saúde 2017-11 /pmc/articles/PMC5661895/ /pubmed/29091132 http://dx.doi.org/10.1590/0074-02760170109 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Campos, Taís M
Costa, Rúbia
Passos, Sara
Carvalho, Lucas P
Cytotoxic activity in cutaneous leishmaniasis
title Cytotoxic activity in cutaneous leishmaniasis
title_full Cytotoxic activity in cutaneous leishmaniasis
title_fullStr Cytotoxic activity in cutaneous leishmaniasis
title_full_unstemmed Cytotoxic activity in cutaneous leishmaniasis
title_short Cytotoxic activity in cutaneous leishmaniasis
title_sort cytotoxic activity in cutaneous leishmaniasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661895/
https://www.ncbi.nlm.nih.gov/pubmed/29091132
http://dx.doi.org/10.1590/0074-02760170109
work_keys_str_mv AT campostaism cytotoxicactivityincutaneousleishmaniasis
AT costarubia cytotoxicactivityincutaneousleishmaniasis
AT passossara cytotoxicactivityincutaneousleishmaniasis
AT carvalholucasp cytotoxicactivityincutaneousleishmaniasis